// App-Quantinova.ai

EP532 : POPULATION-BASED COHORT STUDY OF THE EFFICACY OF BRENTUXIMAB-VEDOTIN IN RELAPSED SYSTEMIC ANAPLASTIC LARGE CELL LYMPHOMA USING PUBLIC HEALTH ENGLAND DATA

Researchers

Presenter

  • Sarah Halligan

Principal Investigators

  • Matthew J Grainge

  • Nicolas Martinez-Calle

  • Christopher P Fox

  • Mark Bishton

Medical Centers

  • Department of Haematology, Nottingham City Hospital, Nottingham, United Kingdom

  • Division of Epidemiology and Public Health, School of Community Health Sciences, University of Nottingham, Nottingham, United Kingdom

  • Nottingham University City Hospital NHS Trust, Nottingham, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Lymphomas

Biomarkers

  • Anaplastic lymphoma Kinase

Drug/Treatment

  • Adcetris

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved